Evidence map›Paper›PMID 39057056›Full record

ArticleCurrent issues in molecular biology2024

Viviane da C Silva, Raquel L de F Teixeira, Rebecca E E N O do Livramento, Márcia Q P Lopes, Thyago Leal-Calvo, José E Filho, Márcia B V Luduvice, Lilian de C Rodrigues, Marcello Bossois, Patricia F Schlinkert and 4 more

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Advances in the Association Between theCurrent issues in molecular biology · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Viviane da C SilvaLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, RJ, Brazil.
Raquel L de F TeixeiraLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0003-3029-6159
Rebecca E E N O do LivramentoLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, RJ, Brazil.
Márcia Q P LopesLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, RJ, Brazil.
Thyago Leal-CalvoLeprosy Laboratory, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0001-9520-4791
José E FilhoDepartamento de Clínica Médica, Faculdade de Medicina, Federal University of Rio de Janeiro, Rio de Janeiro 21941-617, RJ, Brazil.
Márcia B V LuduvicePneumology Department, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro 21941-617, RJ, Brazil.
Lilian de C RodriguesPneumology Department, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro 21941-617, RJ, Brazil.
Marcello BossoisProjeto Brasil sem Alergia, Duque de Caxias 25070-350, RJ, Brazil.
Patricia F SchlinkertProjeto Brasil sem Alergia, Duque de Caxias 25070-350, RJ, Brazil.
Anderson S NevesProjeto Brasil sem Alergia, Duque de Caxias 25070-350, RJ, Brazil.
Philip N SuffysLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, RJ, Brazil.
José Roberto Lapa E SilvaInstitute of Thoracic Medicine, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro 21941-617, RJ, Brazil.ORCID 0000-0003-3116-0253
Adalberto R SantosLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0002-9514-4589

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asthma is a chronic inflammatory respiratory condition, characterized by variable airflow limitation, leading to clinical symptoms such as dyspnea and chest tightness. These symptoms result from an underlying inflammatory process. The β2 agonists are bronchodilators prescribed for the relief of the disease. Nevertheless, their efficacy exhibits substantial interindividual variability. Currently, there is widespread recognition of the association between specific genetic variants, predominantly located within the

Indexed as

ADCY9ADRB2asthmapharmacogeneticspolymorphisms

Identifiers

PMID39057056
PMCPMC11276142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.